Rigel Reports Second Quarter 2026 Financial Results
Go back to Rigel Reports Second Quarter 2026 Financial Results| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 38.70 +1.27 (3.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $37.43 | 52 Week High | $4.38 | |||
| Open | $37.94 | 52 Week Low | $1.88 | |||
| Day High | $39.45 | P/E | N/A | |||
| Day Low | $37.70 | EPS | $-1.12 | |||
| Volume | 333,933 | |||||
